Newsroom

Plexus Technology Group, LLC (Plexus TG), a market-leading, best-of-breed provider of anesthesia information management systems (AIMS), is pleased to announce that Anesthesia Touch™ is ready for Apple’s iOS 12. Clients that wish to upgrade their devices to iOS 12 should coordinate with Plexus TG support. 

“As a professional, mission critical application, we want to ensure Anesthesia Touch on iOS works with the latest version from Apple. This ensures our customers benefit from the significant performance improvements in the release and continued security enhancements,” said Tony Mira, CEO of Plexus Technology Group.

Doug Marcey, CTO, continues, “Because Anesthesia Touch works across iOS, Windows and a cloud-hosted server environment, our Development and Quality Assurance teams are always working to ensure we support these major releases in tandem as quickly as possible. We want to ensure customers can update their devices to take advantage of the new software.”

To learn more about Apple’s latest iOS version, please visit www.apple.com/ios/ios-12. Customers are encouraged to contact customer support with any questions about updating their iOS devices, via support.plexustg.com, email, phone or text. 

About Plexus Technology Group
Plexus Technology Group, a subsidiary of MiraMed Global Services, is a leading provider of anesthesia information management and medication management systems.  Anesthesia Touch is a full-featured AIMS for both Windows and iOS platforms that supports concurrent charting and automatically records physiological data. It is easy to use, enhances patient safety, provides comprehensive anesthesia documentation and is certified as a full EHR for meaningful use.  Pharmacy Touch a modular add-on to Anesthesia Touch, automates controlled substance reconciliation, eliminates duplicate documentation, reduces drug errors and delivers charge capture and decision support at the point of care. 

Contact Info:
Jennifer Dixon, Director of Communications
781.915.0221
This email address is being protected from spambots. You need JavaScript enabled to view it.